Lathrop Investment Management Corp Acquires 3,125 Shares of Danaher Co. (NYSE:DHR)

Lathrop Investment Management Corp raised its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 13.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,705 shares of the conglomerate's stock after acquiring an additional 3,125 shares during the period. Lathrop Investment Management Corp's holdings in Danaher were worth $7,147,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MQS Management LLC purchased a new stake in Danaher in the first quarter valued at $230,000. CreativeOne Wealth LLC acquired a new position in shares of Danaher in the 1st quarter valued at $250,000. Advisors Asset Management Inc. increased its position in shares of Danaher by 3.2% during the first quarter. Advisors Asset Management Inc. now owns 9,277 shares of the conglomerate's stock worth $2,317,000 after purchasing an additional 290 shares in the last quarter. Bank of Nova Scotia Trust Co. boosted its holdings in shares of Danaher by 0.4% in the first quarter. Bank of Nova Scotia Trust Co. now owns 42,598 shares of the conglomerate's stock valued at $10,638,000 after acquiring an additional 165 shares during the period. Finally, Magnetar Financial LLC grew its position in Danaher by 298.2% during the 1st quarter. Magnetar Financial LLC now owns 140,503 shares of the conglomerate's stock worth $35,086,000 after purchasing an additional 105,216 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 0.1 %

Danaher stock traded up $0.18 during trading hours on Friday, hitting $235.23. The stock had a trading volume of 1,318,290 shares, compared to its average volume of 2,756,671. The business's 50 day simple moving average is $258.92 and its 200-day simple moving average is $259.96. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a one year low of $215.68 and a one year high of $281.70. The stock has a market cap of $169.90 billion, a price-to-earnings ratio of 44.80, a P/E/G ratio of 4.25 and a beta of 0.85.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. During the same period last year, the business earned $2.02 EPS. Danaher's quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. Danaher's dividend payout ratio (DPR) is currently 20.61%.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DHR. Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. TD Cowen boosted their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Royal Bank of Canada dropped their price objective on Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Robert W. Baird decreased their price objective on Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Finally, Evercore ISI upped their price objective on Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.